Abstract
Clinical cancer chemoprevention started by studying natural agents presumed to be virtually free of toxicity. Beginning with these agents, however, the history of the major cancer chemoprevention trials has shown that evaluating adverse effects is every bit as important as evaluating preventive
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
